Abstract
SummaryHuman or rabbit plasma kallikrein in highly purified form accelerated the partial thromboplastin test of rabbit, but not human, plasma in a dose-dependent fashion. The clot-promoting effect of kallikrein was inhibited by preincubation with plasma or by treatment of the enzyme with plasma α2-macroglobulin or soybean inhibitors. Prekallikrein did not substitute for the coagulation abnormalities of human plasma deficient in Hageman factor, plasma thromboplastin antecedent, Christmas factor or antihemophilic globulin.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
